November Best Growth Stocks

Equity Financial Holdings is one of many stocks the market is bullish on. Its expected double-digit top-line and bottom-line growth exceeds its peers, and its financially stable position lessens the chances of risk. If a buoyant growth prospect is what you’re after in your next investment, I’ve put together a list of high-growth stocks you may be interested in, based on the latest financial data from each company.

Equity Financial Holdings Inc. (TSX:EQI)

Equity Financial Holdings Inc., a financial services company, through its subsidiary, Equity Financial Trust Company, provides alternative residential mortgage loans to non-prime and near-prime customers in Canada. The company now has 98 employees and with the company’s market cap sitting at CAD CA$93.05M, it falls under the small-cap stocks category.

EQI’s forecasted bottom line growth is an exceptional triple-digit, driven by the underlying 73.89% sales growth over the next few years. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 20.18%. EQI ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Thinking of investing in EQI? Take a look at its other fundamentals here.

TSX:EQI Future Profit Nov 24th 17
TSX:EQI Future Profit Nov 24th 17

SEMAFO Inc. (TSX:SMF)

SEMAFO Inc., a mining company, engages in the exploration and production of gold properties in West Africa. Established in 1994, and currently run by Benoit Desormeaux, the company employs 1,695 people and with the stock’s market cap sitting at CAD CA$1.08B, it comes under the small-cap stocks category.

SMF’s projected future profit growth is an exceptional triple-digit, with an underlying 96.12% growth from its revenues expected over the upcoming years. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a positive return on equity of 13.60%. SMF ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Considering SMF as a potential investment? I recommend researching its fundamentals here.

TSX:SMF Future Profit Nov 24th 17
TSX:SMF Future Profit Nov 24th 17

Cardiome Pharma Corp. (TSX:COM)

Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of patients suffering from heart diseases. Established in 1986, and currently lead by William Hunter, the company provides employment to 75 people and with the company’s market capitalisation at CAD CA$67.53M, we can put it in the small-cap category.

Extreme optimism for COM, as market analysts projected an outstanding earnings growth rate of 62.06% for the stock, supported by an equally strong sales. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. COM ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Considering COM as a potential investment? Check out its fundamental factors here.

TSX:COM Future Profit Nov 24th 17
TSX:COM Future Profit Nov 24th 17

For more financially robust companies with high growth potential to enhance your portfolio, use our free platform to explore our interactive list of these stocks.